A retrospective analysis comparing efficacy of filgastrim-sndz versus filgastrim for autologous, peripheral stem cell mobilization in patients with multiple myeloma and lymphoma

Autor:	Bassam I. Mattar, Seth Joel Page, Pavan S. Reddy, Phu Van Truong, Jeremy M Deutsch, Chris Dakhil, Derek Young, Nassim H. Nabbout, Michael W. Cannon, Shaker R. Dakhil, Patricia Bluml, Quoc Truong
Rok vydání:	2018
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry Stem cell mobilization Biosimilar medicine.disease Granulocyte colony-stimulating factor Lymphoma Peripheral Internal medicine medicine In patient Stem cell business Multiple myeloma
Zdroj:	Journal of Clinical Oncology. 36:e19505-e19505
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2018.36.15_suppl.e19505
Popis:	e19505Background: Filgrastim-sndz was the first biosimilar granulocyte colony stimulating factor to be approved by the FDA for the same indications, including peripheral blood stem cell mobilizatio...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::50afa7d6ec2876e49a9acd9bbd2b19e8 https://doi.org/10.1200/jco.2018.36.15_suppl.e19505 Zobrazit plný text záznamu